Industry, FDA Coordination Key To Diagnostic Test Availability – McClellan
This article was originally published in The Gray Sheet
Executive Summary
FDA and CDC will coordinate efforts to provide standardized specimens of severe acute respiratory syndrome (SARS) to manufacturers by year-end to aid in validating diagnostics for the disease
You may also be interested in...
FDA, CDC Address Disease Outbreak Test Development In Wake Of SARS
The investigational device exemption process for diagnostic tests related to disease outbreaks should be expedited, FDA acknowledges
NIH, FDA Respond To SARS Epidemic: Diagnostics, Medical Supply Stockpile
A sensitive and specific diagnostic for severe acute respiratory syndrome will be available in six to 12 months, NIAID Director Anthony Fauci, MD, averred at a May 7 House Energy & Commerce/Oversight & Investigations Subcommittee hearing
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”